Anchor Bay Capital’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.46K Hold
50
– – ﹤0.01% 269
2026
Q2
$11K Hold
50
– – 0.01% 249

Other funds holding AXSM

Anchor Bay Capital's AXSM Position: Q3 2026 in Review

Anchor Bay Capital held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 50 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Anchor Bay Capital first reported a position in AXSM in Q2 2026 and has held it in 2 quarters since. The position peaked at $11K in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Anchor Bay Capital held 50 shares of Axsome Therapeutics worth $7.46K as of Q3 2026.
  • Anchor Bay Capital left its Axsome Therapeutics share count unchanged in Q3 2026.
  • Axsome Therapeutics made up ﹤0.01% of Anchor Bay Capital's portfolio in Q3 2026, its #269 holding.
  • Anchor Bay Capital first reported a position in Axsome Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Anchor Bay Capital's Axsome Therapeutics position peaked at $11K in Q2 2026.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Anchor Bay Capital's 13F filing for Q3 2026, filed 13 Nov 2026.